219 related articles for article (PubMed ID: 19809387)
1. Vancomycin continuous infusion as prophylaxis for vascular surgery.
Payne CJ; Carmichael SJ; Stearns AT; Kingsmore DB; Byrne DS; Binning AR
Ther Drug Monit; 2009 Dec; 31(6):786-8. PubMed ID: 19809387
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue penetration of vancomycin continuous infusion as prophylaxis for vascular surgery.
Payne CJ; Thomson AH; Stearns AT; Watson DG; Zhang T; Kingsmore DB; Byrne DS; Binning AS
J Antimicrob Chemother; 2011 Nov; 66(11):2624-7. PubMed ID: 21840937
[TBL] [Abstract][Full Text] [Related]
3. Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant enterococcus colonization.
Kachroo S; Dao T; Zabaneh F; Reiter M; Larocco MT; Gentry LO; Garey KW
Ann Pharmacother; 2006 Mar; 40(3):381-5. PubMed ID: 16478809
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial.
Maki DG; Bohn MJ; Stolz SM; Kroncke GM; Acher CW; Myerowitz PD
J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1423-34. PubMed ID: 1434726
[TBL] [Abstract][Full Text] [Related]
5. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E
Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of post-cardiopulmonary bypass dosing of vancomycin in cardiac surgery.
Raikhelkar JK; Reich DL; Schure R; Varghese R; Bodian C; Scurlock C
Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):301-4. PubMed ID: 20841364
[TBL] [Abstract][Full Text] [Related]
7. Continuous versus intermittent infusion of prophylactic cefoxitin after colorectal surgery: a pilot study.
Suffoletta TJ; Jennings HR; Oh JJ; Stephens D; Poe KL
Pharmacotherapy; 2008 Sep; 28(9):1133-9. PubMed ID: 18752384
[TBL] [Abstract][Full Text] [Related]
8. Economic benefit of appropriate timing of vancomycin prophylaxis in patients undergoing cardiovascular surgery.
Garey KW; Amrutkar P; Dao-Tran TK; Frost CP; Chen H; Essien EJ; Gentry LO
Pharmacotherapy; 2008 Jun; 28(6):699-706. PubMed ID: 18503397
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
[TBL] [Abstract][Full Text] [Related]
10. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.
Plan O; Cambonie G; Barbotte E; Meyer P; Devine C; Milesi C; Pidoux O; Badr M; Picaud JC
Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F418-21. PubMed ID: 18450803
[TBL] [Abstract][Full Text] [Related]
11. Serum and synovial vancomycin concentrations following prophylactic administration in knee arthroplasty.
Eshkenazi AU; Garti A; Tamir L; Hendel D
Am J Knee Surg; 2001; 14(4):221-3. PubMed ID: 11703034
[TBL] [Abstract][Full Text] [Related]
12. Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections.
Garey KW; Dao T; Chen H; Amrutkar P; Kumar N; Reiter M; Gentry LO
J Antimicrob Chemother; 2006 Sep; 58(3):645-50. PubMed ID: 16807254
[TBL] [Abstract][Full Text] [Related]
13. [Vancomycin and teicoplanin use as antibiotic prophylaxis in cardiac surgery: pharmacoeconomic study].
Codina C; Miró JM; Tuset M; Claramonte J; Gomar C; Gotsens R; Gómez B; Suárez S; Abellana R; Ascaso C; Cartaña R; Rodríguez E; Asenjo M; Carné X; Trilla A; Marco F; Gómez J; Brunet M; Pomar JL; Gatell JM; Ribas J
Med Clin (Barc); 2000; 114 Suppl 3():54-61. PubMed ID: 10994565
[TBL] [Abstract][Full Text] [Related]
14. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
Atahan E; Gul M; Ergun Y; Eroglu E
Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
[TBL] [Abstract][Full Text] [Related]
15. [Antibiotic chemoprophylaxis in orthopedic prosthesis implantation].
de Lalla F
J Chemother; 2000 Jul; 12 Suppl 2():23-7. PubMed ID: 11428097
[TBL] [Abstract][Full Text] [Related]
16. Cefazolin bolus and continuous administration for elective cardiac surgery: improved pharmacokinetic and pharmacodynamic parameters.
Adembri C; Ristori R; Chelazzi C; Arrigucci S; Cassetta MI; De Gaudio AR; Novelli A
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):471-5. PubMed ID: 20570290
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic prophylaxis in prosthetic penile surgery: critical assessment of results in 75 consecutive patients.
Maffezzini M; Capone M; Ciampalini S; De Stefani SD; Simonato A; Carmignani G
Int J Impot Res; 1996 Jun; 8(2):87-9. PubMed ID: 8858397
[TBL] [Abstract][Full Text] [Related]
18. [Experimental study on the prevention of vascular prosthetic infection with an antibiotic-bonded dacron graft].
Yu WP; Jing ZP; Bao JM; Zhao ZQ; Zhao J
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):348-9. PubMed ID: 15854516
[No Abstract] [Full Text] [Related]
19. Outbreak of acute renal failure due to cefodizime-vancomycin association in a heart surgery unit.
Fiaccadori E; Maggiore U; Arisi A; Cabassi A; Beghi C; Campodonico R; Gherli T
Intensive Care Med; 2001 Nov; 27(11):1819-22. PubMed ID: 11810128
[TBL] [Abstract][Full Text] [Related]
20. [Continuous infusion of vancomycin during the neonatal period].
Borderon JC; Laugier J; Chamboux C; Saliba E; Mathieu A
Pathol Biol (Paris); 1994 May; 42(5):525-9. PubMed ID: 7824326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
